Mild Cognitive Impairment (MCI) Treatment Market: Advancing Neurological Care and Early Interventions

The mild cognitive impairment (MCI) treatment market is gaining momentum as awareness of early-stage neurological disorders increases. Rising prevalence of Alzheimer’s disease, dementia, and age-related cognitive decline is driving demand for diagnostic tools, therapies, and preventive healthcare strategies.